Evidence map›Paper›PMID 40175650›Full record

ArticleOncogene2025

Alternative splicing of bunched confers a dual role in hippo pathway-dependent growth and tumorigenesis.

Pengjuan Guo, Sha Song, Yuxiao Niu, Xiaoyu Kuang, Dafa Zhou, Zizhang Zhou, Yanxiao Zhang, Xianjue Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pengjuan Guo *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China.
Sha Song *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China.
Yuxiao Niu *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China.
Xiaoyu KuangWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China.
Dafa ZhouCollege of Life Sciences, Shandong Agricultural University, Tai'an, Shandong, 271018, China.
Zizhang ZhouCollege of Life Sciences, Shandong Agricultural University, Tai'an, Shandong, 271018, China.ORCID http://orcid.org/0000-0001-5883-8218
Yanxiao ZhangWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China. zhangyanxiao@westlake.edu.cn.ORCID http://orcid.org/0000-0001-9618-637X
Xianjue MaWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, 310024, China. maxianjue@westlake.edu.cn.ORCID http://orcid.org/0000-0003-4360-3947

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32170824National Natural Science Foundation of China (National Science Foundation of China) 32322027National Natural Science Foundation of China (National Science Foundation of China) 32370710
6 · The paper itself

Abstract

Alternative splicing is a fundamental mechanism that generates functionally distinct proteins from individual genes, contributing to gene regulation and proteomic diversity. In Drosophila, the bunched (bun) gene, a member of the TSC-22 domain gene family, undergoes alternative splicing, yielding diverse protein isoforms involved in crucial biological processes. Nevertheless, the specific roles and regulatory mechanisms of each isoform remain elusive. Here, we employed CRISPR/Cas9 technology to introduce targeted deletions within the endogenous locus of the bun gene, resulting in the removal of either long or short isoforms. We discovered that the short isoforms demonstrated a growth-suppressive role, whereas the long isoforms exhibited a growth-promoting effect. Surprisingly, the long isoforms exhibited a remarkable dual functionality, as both deletion and amplification of long isoform expression impede the excess growth induced by Hippo pathway inactivation. Mechanistically, ectopically expressed Bun long isoforms act as the transcriptional suppressor by competitively binding to targets' promoter regions in conjunction with Yorkie/Scalloped (Yki/Sd), thereby inhibiting its transcriptional outputs and ultimately leading to the growth suppression. These findings unveil the intricate interaction between distinct spliced isoforms of Bun and oncogenic outcomes, highlighting Bun long isoforms as the critical transcription suppressor regulating Hippo pathway inactivation-mediated growth and tumorigenesis in Drosophila.

Indexed as

Alternative SplicingCarcinogenesisDrosophila ProteinsIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesAnimalsCell ProliferationCRISPR-Cas SystemsDrosophila melanogasterHippo KinasesHippo Signaling PathwayNuclear ProteinsProtein IsoformsSignal TransductionTrans-ActivatorsTranscription FactorsDrosophila ProteinsHippo Kinaseshpo protein, DrosophilaIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein IsoformsProtein Serine-Threonine KinasesTrans-ActivatorsTranscription FactorsYAP-Signaling ProteinsYki protein, Drosophila

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.